Reconstructive local injection therapy
DOI: 10.32364/2587-6821-2024-8-4-4
Yu.S. Filatova1,2, I.N. Solovyov1,2, E.I. Solovyov1
1Yaroslavl State Medical University, Yaroslavl, Russian Federation
2Medical Center for Diagnostics and Prevention Plus LLC, Yaroslavl, Russian Federation
The article discusses the treatment of osteoarthritis (OA) as the most common joint disease. The recommendations from professional associations for the patient management in OA using hyaluronic acid (HA) preparations differ somewhat depending on the affected joint, although they generally indicate positive effects of their use. Studies have shown the HA participation in the phagocytosis reduction, as well as in lowering the levels of prostaglandins, fibronectin, cAMP and a number of other anti-inflammatory effects. There is also a hypothesis that HA can prevent the release of arachidonic acid, block nociceptors and reduce the bradykinin formation, as well as it has chondroprotective properties. At the same time, total joint replacement is considered optimal (which has proven itself to be an effective and safe type of surgery) during the OA progression, the preservation of severe pain and loss of joint function, and the inefficacy of conservative treatment. The authors draw attention to the most common complication that occurs during total joint replacement — contralateral limb pain, and explain the mechanisms of its progression. They also present their case follow-ups of patients after total joint replacement with the development of synovitis in the contralateral hip joint and synovitis in combination with ligamentitis in the contralateral knee joint. Besides, the article highlights the clinical picture patterns and the methods of reconstructive local injection therapy with HA.
Keywords: osteoarthritis, knee joint, hip joint, hyaluronic acid, total joint replacement, contralateral limb pain, intra-articular injection, periarticular injection.
For citation: Filatova Yu.S., Solovyov I.N., Solovyov E.I. Reconstructive local injection therapy. Russian Medical Inquiry. 2024;8(4):–214 (in Russ.). DOI: 10.32364/2587-6821-2024-8-4-4.
ABOUT THE AUTHORS:
Yulia S. Filatova — C. Sc. (Med.), Associate Professor of the Department of Therapy named after E.N. Dormidontov, Institute of Continuing Professional Education, Yaroslavl State Medical University; 5, Revolyutsionnaya str., Yaroslavl, 150000, Russian Federation; rheumatologist, Medical Center for Diagnostics and Prevention Plus LLC; 33, Lenin av., Yaroslavl, 150040, Russian Federation; ORCID iD 0000-0003-3024-9483.
Igor N. Solovyov — C. Sc. (Med.), Associate Professor of the Department of Traumatology and Orthopedics, Yaroslavl State Medical University; 5, Revolyutsionnaya str., Yaroslavl, 150000, Russian Federation; orthopedic traumatologist, Medical Center for Diagnostics and Prevention Plus LLC; 33, Lenin av., Yaroslavl, 150040, Russian Federation; ORCID iD 0000-0002-9347-1551.
Egor I. Solovyov — 5th-year student of the Faculty of Medicine, Yaroslavl State Medical University; 5, Revolyutsionnaya str., Yaroslavl, 150000, Russian Federation; ORCID iD 0009-0004-3138-0824.
Contact information: Yulia S. Filatova, e-mail: y.s.filatova@mail.ru.
Financial Disclosure: the authors have no financial or property interest in any material or method mentioned.
There is no conflict of interest.
Received 21.02.2024.
Revised 20.03.2024.
Accepted 12.04.2024.
2. Bannuru R.R., Osani M.C., Vaysbrot E.E. et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578–1589. DOI: 10.1016/j.joca.2019.06.011.
3. Kolasinski S.L., Neogi T., Hochberg M.C. et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res (Hoboken). 2020;72(2):149–162. DOI: 10.1002/acr.24131.
4. Brophy R.H., Fillingham Y.A. AAOS Clinical Practice Guideline Summary: Management of Osteoarthritis of the Knee (Nonarthroplasty), Third Edition. J Am Acad Orthop Surg. 2022;30(9):e721-e729. DOI: 10.5435/JAAOS-D-21-01233.
5. Kloppenburg M., Kroon F.P., Blanco F.J. et al. 2018 update of the EULAR recommendations for the management of hand osteoarthritis. Ann Rheum Dis. 2019;78(1):16–24. DOI: 10.1136/annrheumdis-2018-213826.
6. Bruyère O., Honvo G., Veronese N. et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019;49(3):337–350. DOI: 10.1016/j.semarthrit.2019.04.008.
7. Farì G., Megna M., Scacco S. et al. Hemp Seed Oil in Association with β-Caryophyllene, Myrcene and Ginger Extract as a Nutraceutical Integration in Knee Osteoarthritis: A Double-Blind Prospective Case-Control Study. Medicina. 2023;59:191. DOI: 10.3390/medicina59020191.
8. Tran K., Loshak H. Intra-Articular Hyaluronic Acid for Viscosupplementation in Osteoarthritis of the Hand, Shoulder, and Temporomandibular Joint: A Review of Clinical Effectiveness and Safety [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jul 25. PMID: 31553549.
9. Householder N.A., Raghuram A., Agyare K. et al. A review of recent innovations in cartilage regeneration strategies for the treatment of primary osteoarthritis of the knee: intra-articular injections. Orthop J Sport Med. 2023;11:23259671231155950. DOI: 10.1177/23259671231155950.
10. Marinho A., Nunes C., Reis S. Hyaluronic Acid: A Key Ingredient in the Therapy of Inflammation. Biomolecules. 2021;11:1518. DOI: 10.3390/biom11101518.
11. Altman R., Bedi A., Manjoo A. et al. Anti-Inflammatory Effects of Intra-Articular Hyaluronic Acid: A Systematic Review. Cartilage. 2019;10:43–52. DOI: 10.1177/1947603517749919.
12. Richards M.M., Maxwell J.S., Weng L. et al. Intra-articular treatment of knee osteoarthritis: From anti-inflammatories to products of regenerative medicine. Phys Sport. 2016;44:101–108. DOI: 10.1080/00913847.2016.1168272.
13. Murakami T., Otsuki S., Okamoto Y. et al Hyaluronic acid promotes proliferation and migration of human meniscus cells via a CD44-dependent mechanism. Connect. Tissue Res. 2019;60:117–127. DOI: 10.1080/03008207.2018.1465053.
14. Ishijima M., Nakamura T., Shimizu K. et al. Different changes in the biomarker C-terminal telopeptides of type II collagen (CTX-II) following intra-articular injection of high molecular weight hyaluronic acid and oral non-steroidal anti-inflammatory drugs in patients with knee osteoarthritis: A multi-center randomized controlled study. Osteoarthritis Cartilage. 2022;30:852–861. DOI: 10.1016/j.joca.2022.03.003.
15. Honvo G., Reginster J.Y., Rannou F. et al. Safety of Intra-articular Hyaluronic Acid Injections in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis. Drugs Aging. 2019;36(Suppl S1):101–127. DOI: 10.1007/s40266-019-00657-w.
16. Chavda S., Rabbani S.A., Wadhwa T. Role and Effectiveness of Intra-articular Injection of Hyaluronic Acid in the Treatment of Knee Osteoarthritis: A Systematic Review. Cureus. 2022;14:e24503. DOI: 10.7759/cureus.24503.
17. Coryell P.R., Diekman B.O., Loeser R.F. Mechanisms and therapeutic implications of cellular senescence in osteoarthritis. Nat Rev Rheumatol. 2021;17:47–57. DOI: 10.1038/s41584-020-00533-7.
18. Raeissadat S.A., Ghazi Hosseini P., Bahrami M.H. et al. The comparison effects of intra-articular injection of Platelet Rich Plasma (PRP), Plasma Rich in Growth Factor (PRGF), Hyaluronic Acid (HA), and ozone in knee osteoarthritis; a one year randomized clinical trial. BMC Musculoskelet Disord. 2021;22:134. DOI: 10.1186/s12891-021-04017-x.
19. Billesberger L.M., Fisher K.M., Qadri Y.J. et al. Procedural Treatments for Knee Osteoarthritis: A Review of Current Injectable Therapies. Pain Res Manag. 2020;2020:3873098. DOI: 10.1155/2020/3873098.
20. Luo Y., Tan J., Zhou Y. et al. From crosslinking strategies to biomedical applications of hyaluronic acid-based hydrogels: A review. Int J Biol Macromol. 2023;231:123308. DOI: 10.1016/j.ijbiomac.2023.123308.
21. Furuta J., Ariyoshi W., Okinaga T. et al. High molecular weight hyaluronic acid regulates MMP13 expression in chondrocytes via DUSP10/MKP5. J Orthop Res. 2017;35:331–333. DOI: 10.1002/jor.23266.
22. Филатова Ю.С., Соловьев И.Н. Гиалуроновая кислота в лечении остеоартрита различных локализаций. Обзор литературы. Терапевтический архив. 2022;94(8):1014–1019. DOI: 10.26442/00403660.2022.08.201790.Filatova Y.S., Soloviev I.N. Hyaluronic acid in the treatment of osteoarthritis of various localization: A review. Terapevticheskii arkhiv. 2022;94(8):1014–1019 (in Russ.). DOI: 10.26442/00403660.2022.08.201790.
23. Caneiro J.P., O'Sullivan P.B., Roos E.M. et al. Three steps to changing the narrative about knee osteoarthritis care: a call to action. Br J Sports Med. 2020;54(5):256–258. DOI: 10.1136/bjsports-2019-101328.
24. Katz J.N., Arant K.R., Loeser R.F. Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review. JAMA. 2021;325(6):568–578. DOI: 10.1001/jama.2020.22171.
25. López-López J.A., Humphriss R.L., Beswick A.D. et al. Choice of implant combinations in total hip replacement: systematic review and network meta-analysis. BMJ. 2017;359:j4651. DOI: 10.1136/bmj.j4651.
26. Nilsdotter A.K., Petersson I.F., Roos E.M. et al. Predictors of patient relevant outcome after total hip replacement for osteoarthritis: a prospective study. Ann Rheum Dis. 2003;62(10):923–930. DOI: 10.1136/ard.62.10.923.
27. Мурылев В., Музыченков А., Жучков А. и др. Тотальное эндопротезирование коленного сустава при посттравматических деформациях нижних конечностей. Врач. 2015;11:4–7.Murylev V., Muzychenkov A., Zhuchkov A. et al. Total endoprosthetic replacement of the knee joint for posttraumatic deformities of the lower limbs. Vrach. 2015;11:4–7 (in Russ.).
28. Shao Y., Zhang C., Charron K.D. et al. The fate of the remaining knee(s) or hip(s) in osteoarthritic patients undergoing a primary TKA or THA. J Arthroplasty. 2013;28(10):1842–1845. DOI: 10.1016/j.arth.2012.10.008.
29. Zeni J., Snyder-Mackler L. Baseline differences between individuals who did and did not have contralateral symptomatic OA progression after TKA. Osteoarthritis and Cartilage. 2016;24(2016):S103. DOI: 10.1016/j.joca.2016.01.209.
30. Zeni J.A., Flowers P., Bade M. et al. L. Stiff knee gait may increase risk of second total knee arthroplasty. J Orthop Res. 2019;37(2):397–402.DOI: 10.1002/jor.24175.
31. Miyazaki T., Wada M., Kawahara H. et al. Dynamic load at baseline can predict radiographic disease progression in medial compartment knee osteoarthritis. Ann Rheum Dis. 2002;61(7):617–622. DOI: 10.1136/ard.61.7.617.
32. Aljehani M., Madara K., Snyder-Mackler L. et al. The contralateral knee may not be a valid control for biomechanical outcomes after unilateral total knee arthroplasty. Gait Posture. 2019;70:179–184. DOI: 10.1016/j.gaitpost.2019.01.030.
33. Alnahdi A.H., Zeni J.А., Snyder-Mackler L. Gait after unilateral total knee arthroplasty: Frontal plane analysis. J Orthop Res. 2011;29(5):647–652. DOI: 10.1002/jor.21323.
34. Christiansen C.L., Bade M.J., Judd D.L., Stevens-Lapsley J.E. Weight-bearing asymmetry during sit-stand transitions related to impairment and functional mobility after total knee arthroplasty. Arch Phys Med Rehabil. 2011;92(10):1624–1629. DOI: 10.1016/j.apmr.2011.05.010.
35. Felson D.T. Osteoarthritis as a disease of mechanics. Osteoarthritis Cartilage. 2013;21(1):10–15. DOI: 10.1016/j.joca.2012.09.012.
36. Andriacchi T.P., Mündermann A. The role of ambulatory mechanics in the initiation and progression of knee osteoarthritis. Curr Opin Rheumatol. 2006;18(5):514–518. DOI: 10.1097/01.bor.0000240365.16842.4e.
37. Diamond L.E., Grant T., Uhlrich S.D. Osteoarthritis year in review 2023: Biomechanics. Osteoarthritis Cartilage. 2024;32(2):138–147. DOI: 10.1016/j.joca.2023.11.015.
38. Burr D.B. Anatomy and physiology of the mineralized tissues: role in the pathogenesis of osteoarthrosis. Osteoarthritis Cartilage. 2004;12(Suppl A):S20–30. DOI: 10.1016/j.joca.2003.09.016.
39. Han X., Cui J., Chu L. et al. Abnormal subchondral trabecular bone remodeling in knee osteoarthritis under the influence of knee alignment. Osteoarthritis Cartilage. 2022;30(1):100–109. DOI: 10.1016/j.joca.2021.10.005.
40. Тицкая Е.В., Смирнова И.Н., Мирютова Н.Ф. и др. Комплексная реабилитация больных остеоартрозом после тотального эндопротезирования тазобедренных суставов в позднем реабилитационном периоде. Физиотерапия, бальнеология и реабилитация. 2015;14(1):1–25.Titskaya E.V., Smirnova I.N., Miryutova N.F. et al. The combined rehabilitative treatment of the patients presenting with osteoarthrosis following total hip endoprosthetic replacement during the late postoperative period. Fizioterapiya, bal'neologiya i reabilitatsiya. 2015;14(1):1–25 (in Russ.).
41. Чибриков А.Г., Гражданов К.А., Пономарев И.Р., Зуев П.П. Эффективность применения высокомолекулярных препаратов гиалуроновой кислоты при тотальной артропластике коленного сустава. Современные проблемы науки и образования. 2022;6–1. (Электронный ресурс.) URL: https://science-education.ru/ru/article/view?id=32242 (дата обращения: 29.04.2024).Chibrikov A.G., Grazhdanov K.A., Ponomarev I.R., Zuyev P.P. Efficacy of high molecular hyaluronic acid medications in total knee arthroplasty. Modern Problems of Science and Education. 2022;6–1. (Electronic resource.) URL: https://science-education.ru/ru/article/view?id=32242 (access date: 29.04.2024) (in Russ.).
42. Hill C.L., Hunter D.J., Niu J. et al. Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis. Ann Rheum Dis. 2007;66(12):1599–1603. DOI: 10.1136/ard.2006.067470.
43. Ayral X., Pickering E.H., Woodworth T.G. et al. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis — results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage. 2005;13(5):361–367. DOI: 10.1016/j.joca.2005.01.005.
44. Филатова Ю.С., Соловьев И.Н., Груздев А.М. Остеоартрит тазобедренных суставов: возможности локальной терапии. Медицинский совет. 2023;17(21):152–158. DOI: 10.21518/ms2023-407.Filatova Y.S., Solovyov I.N., Gruzdev A.M. Osteoarthritis of the hip joints: possibilities of local therapy. Medical Council. 2023;(21):152–158 (in Russ.). DOI: 10.21518/ms2023-407.
45. Neuenschwander H.M, Moreira J.J., Vendruscolo C.P. et al. Hyaluronic acid has chondroprotective and joint-preserving effects on LPS-induced synovitis in horses. J Vet Sci. 2019;20(6):e67. DOI: 10.4142/jvs.2019.20.e67.
46. Maheu E., Bannuru R.R., Herrero-Beaumont G. et al. Why we should definitely include intra-articular hyaluronic acid as a therapeutic optionin the management of knee osteoarthritis: Results of an extensive critical literature review. Semin Arthritis Rheum. 2019;48:563–572. DOI: 10.1016/j.semarthrit.2018.06.002.
47. Tolba Y.M., Omar S.S., Nagui D.A. et al. Effect of high molecular weight hyaluronic acid in treatment of osteoarthritic temporomandibular joints of rats. Arch Oral Biol. 2020;110:104618. DOI: 10.1016/j.archoralbio.2019.104618.
This work is licensed under a Creative Commons «Attribution» 4.0 License.
